Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: A systematic review and economic evaluation

Health Technology Assessment

Volumn 16, Issue 4, 2012, Pages

  Stevenson, M ^a   Lloyd Jones, M ^a   Morgan, M Y ^b   Wong, R ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ALCOHOL ABSTINENCE; ALCOHOL LIVER DISEASE; ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRINKING BEHAVIOR; ECONOMIC EVALUATION; ELASTOGRAPHY; HEALTH CARE COST; HEPATITIS; HUMAN; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; MATHEMATICAL MODEL; NON INVASIVE MEASUREMENT; PROGNOSIS; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; ALCOHOL LIVER CIRRHOSIS; BIOMEDICAL TECHNOLOGY ASSESSMENT; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; COST CONTROL; DIAGNOSTIC TEST; DOPPLER FLOWMETRY; ECONOMICS; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MALE; METHODOLOGY; NEEDLE BIOPSY; PATHOLOGY; PATIENT SAFETY; REVIEW; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; UNITED KINGDOM;

BIOPSY, NEEDLE; COST SAVINGS; DIAGNOSTIC TESTS, ROUTINE; ELASTICITY IMAGING TECHNIQUES; FEMALE; GREAT BRITAIN; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; PATIENT SAFETY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER;

EID: 84857866996     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta16040     Document Type: Article

References (21)

1. Mann, R. E., Smart, R. G., and Govoni, R. The epidemiology of alcoholic liver disease. Alcohol Research & Health 2003; 27 209-219.
2. Marsano, L. S., Mendez, C., Hill, D., Barve, S., and McClain, C. J. Diagnosis and treatment of alcoholic liver disease and its complications. Alcohol Research & Health 2003; 27 247-256.
3. Walsh, K. and Alexander, G. Alcoholic liver disease. Postgraduate Medical Journal 2000; 76 280-286.
4. Williams, R. The pervading influence of alcoholic liver disease in hepatology. Alcohol & Alcoholism 2008; 43 393-397.
5. The National Clinical Guideline Centre for acute and chronic conditions Alcohol use disorders: diagnosis and clinical management of alcohol-related physical complications. NICE guideline. Draft for consultation. 2009;
6. Fleming, K. M., Aithal, G. P., Solaymani-Dodaran, M., Card, T. R., and West, J. Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: a general populationbased study. Journal of Hepatology 2008; 49 732-738.
7. British Liver Trust Fighting liver disease. Internet 2009;
8. Fuller, E., Jotangia, D., and Farrell, M. Alcohol misuse and dependence. 2009;
9. Statistics for Wales Welsh Health Survey 2008. 2009;
10. Moher, D., Liberati, A., Tetzlaff, J., and Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339 332-339.
11. Whiting, P., Rutjes, A. W., Reitsma, J. B., Bossuyt, P. M., and Kleijnen, J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology 2003; 3 25-
12. Drummond, M. and Jefferson, T. O. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996;275-283.
13. Eddy, D. M. The role of mathematical modeling. 1985;144-154.
14. National Institute for Health and Clinical Excellence Guide to the methods of technology appraisals. Internet 2008;
15. Curtis, L. Unit costs of health and social care. 2008;
16. Claxton, K. and Posnett, J. An economic approach to clinical trial design and research priority-setting. Health Economics 1996; 5 513-524.
17. Felli, J. C. and Hazen, G. B. Sensitivity analysis and the expected value of perfect information. Medical Decision Making 1998; 18 95-109.
18. Ades, A. E., Lu, G., and Claxton, K. Expected values of sample information calculation in medical decision making. Medical Decision Making 2004; 24 207-227.
19. Stevenson, M. D., Oakley, J. E., Lloyd Jones, M., Brennan, A., Compston, J. E., McCloskey, E. V., and Selby, P. L. The cost-effectiveness of an RCT to establish whether 5 or 10 years of bisphosphonate treatment is the better duration for women with a prior fracture. Medical Decision Making 2009; 29 678-689.
20. Stevenson, M. D. and Lloyd Jones, M. Vitamin K to prevent fractures in older women: a systematic review and economic evaluation. Health Technology Assessment 2009; 13(45)
21. Drummond, M and Jefferson, TO Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996; 313 275-283.